Leases (Tables)

3 Months Ended

Mar. 31, 2022

The following table summarizes the impact of the Company's operating leases on its financial statements for each of the periods presented:


	Three Months Ended March 31,
		2022		2021
		(unaudited; in thousands)
Statements of Operations
Operating lease costs		$	439	$	439

		Three Months Ended March 31,
		2022		2021
		(unaudited; in thousands)
Statements of Cash Flows
Operating cash flows from operating leases - cash paid for operating leases		$	508	$	489

The following table summarizes the lease terms and discount rates for the Company's leases as of March 31, 2022:


	(unaudited)
Weighted-average remaining lease term (in years)	2.40
Weighted-average discount rate	11	%

The following table summarizes the maturities of the Company's lease liabilities for each year ending December 31, as of March 31, 2022:


	(unaudited; in thousands)
2022	$	1,534
2023	2,017
2024	1,371
Total undiscounted cash flows	4,922
Less: amount representing interest	(618)
Present value of lease liabilities	$	4,304

Current portion	$	1,642
Long-term portion	2,662
Total	$	4,304

Zosano Pharma Corp 10-Q